Daily Essential Supplements by VāyasLife Even a reasonably balanced diet can leave...
Many women first hear about CoQ10 from a fertility specialist, a friend who conceived after a long and difficult journey, or a late-night search that led somewhere reassuring. The recommendation arrives, sometimes without much explanation, and you are left trying to figure out whether it is genuinely worth taking, what it actually does inside the body, and whether the research behind it holds up.
This article answers those questions properly. It covers what CoQ10 is, why it matters specifically if you have PCOS, what the clinical evidence actually shows, and the practical information you need before your next conversation with your doctor.
Coenzyme Q10 is a fat-soluble compound your body produces naturally and also takes in through food, particularly from meat and fish. Its primary home is the mitochondria, the energy-generating structures present in almost every cell in your body. Inside the mitochondria, CoQ10 performs two important roles. It acts as a carrier in the chain of chemical reactions that produce ATP, the molecule your cells use as their primary energy currency. It also functions as an antioxidant, protecting cells from damage caused by reactive oxygen species, more commonly called free radicals.
Your eggs, technically called oocytes, are among the most energy-demanding cells in the human body. An egg undergoing maturation requires enormous amounts of ATP to divide correctly, maintain chromosomal integrity, and prepare for fertilisation. The quality of that energy supply directly influences whether an egg matures properly, whether fertilisation succeeds, and whether the early embryo develops as it should. This is not a peripheral concern; it sits at the centre of what determines egg quality.
The complication is that your body's ability to produce CoQ10 declines with age, beginning in the mid-thirties. This decline runs parallel to the well-documented drop in egg quality that happens over the same period. Less CoQ10 means less efficient energy production in the mitochondria, which means eggs have less of what they need to develop well. Supplementing with CoQ10 is an attempt to restore that mitochondrial capacity; to give the cells the raw material they can no longer produce in sufficient quantity on their own.
For women with PCOS, the CoQ10 conversation goes deeper than age-related decline. PCOS is associated with two conditions that directly impair mitochondrial function and compound the problem: chronic low-grade inflammation and oxidative stress.
Oxidative stress occurs when the body generates more reactive oxygen species than its antioxidant defences can neutralise. Research consistently shows that women with PCOS carry a higher oxidative load than women without the condition; their cells are exposed to more free radical damage, and their antioxidant capacity is comparatively lower. Since CoQ10's second major role is precisely as a cellular antioxidant, this creates a specific deficit that supplementation can address in a biologically meaningful way.
The second factor is insulin resistance. A significant proportion of women with PCOS (estimated at around 70%) have some degree of insulin resistance. This is not simply a metabolic inconvenience; insulin resistance disrupts mitochondrial function in ways that compound the energy-production problems already present. A 2024 randomised double-blind trial involving forty infertile women with PCOS found that eight weeks of CoQ10 supplementation improved insulin sensitivity markers, reduced fasting insulin, and improved a key gene expression marker related to metabolic regulation. The trial was small but it confirms a mechanistic pathway that demonstrates consistency with broader PCOS research and is credible on its own terms.
This is why CoQ10 comes up specifically in PCOS fertility conversations, not just in discussions of general age-related decline. The combination of oxidative stress, chronic inflammation, and insulin resistance creates a cluster of CoQ10-responsive problems, and addressing them together is part of what makes the supplement relevant for this particular group.
The evidence for CoQ10 in fertility is promising, and in some areas it is genuinely striking.
A 2014 randomised controlled trial recruited 101 women with clomiphene-resistant PCOS; women for whom standard ovulation-induction treatment had already failed. One group received CoQ10 alongside clomiphene citrate; the other received clomiphene alone. In the group that received CoQ10, ovulation occurred in 65.9% of cycles, compared to 15.5% in the group without it. The clinical pregnancy rate was 37.3% versus 6%. These are large differences, and this trial remains one of the most directly relevant pieces of clinical evidence for women with PCOS specifically, particularly those who have not responded to first-line treatment.
A frequently referenced 2018 trial studied women under 35 with poor ovarian reserve who were preparing for IVF. Women who took 600 mg of CoQ10 daily for 60 days before egg retrieval showed improvements in the number of mature eggs retrieved, fertilisation rates, and embryo quality. The live birth rate was higher in the CoQ10 group (28.95% versus 15.54%), though this difference did not reach statistical significance, the trial was not powered to be conclusive on that particular measure. What it establishes clearly is that CoQ10 appears to improve the quality of what the ovaries produce, particularly in women with compromised reserve.
A 2020 systematic review and meta-analysis, which pooled data from multiple randomised trials, found that CoQ10 supplementation increased clinical pregnancy rates in women undergoing assisted reproductive technology. It did not find statistically significant effects on live birth rates or miscarriage rates, largely because the available data was insufficient in volume to support firm conclusions on those outcomes.
A 2025 meta-analysis found that CoQ10 increased live birth rates in women with poor ovarian response and increased pregnancy rates in women with PCOS. The same review found evidence suggesting CoQ10 may reduce aneuploidy (chromosomal abnormalities) in oocytes from older women, a meaningful finding if replicated in larger studies. A 2025 review published in Frontiers in Cell and Developmental Biology also synthesised CoQ10's protective role across oocyte maturation, embryo development, ovarian ageing, and PCOS, supporting the growing body of mechanistic and clinical evidence in this area.
The evidence is strongest for women with PCOS, women with poor ovarian reserve, and women preparing for IVF, particularly those over 35. For younger women under 35 with normal ovarian reserve trying to conceive naturally, the research base is thinner. That does not mean CoQ10 is without benefit in this group, but it means the conclusions are less definitive. An honest reading of the literature is that CoQ10 appears to help most where there is a specific biological problem — oxidative stress, compromised mitochondrial function, or reduced ovarian reserve — rather than acting as a universal fertility booster for all women regardless of their situation.
Based on the current evidence, CoQ10 is most relevant for women with PCOS, particularly those with documented insulin resistance or who have not responded well to first-line ovulation treatments. It is also relevant for women over 35 trying to conceive, where natural CoQ10 decline is a contributing factor to egg quality, and for women preparing for IVF, especially those with poor ovarian reserve or a history of poor response to stimulation. Women who have already been advised by a fertility specialist to consider CoQ10 as part of their preconception protocol are, of course, the most directly served by the research above.
Most fertility protocols suggest beginning CoQ10 supplementation 60 to 90 days before a planned conception attempt or an IVF cycle. This window corresponds roughly to the time it takes for an egg to progress through its final stages of maturation, the developmental period during which mitochondrial health matters most. Starting earlier gives the supplementation time to build up in the tissues and create a meaningful effect.
Doses used in fertility research range from 200 mg to 600 mg per day. The lower end of this range was used in the PCOS metabolic studies; the higher doses featured in IVF pretreatment protocols. The appropriate amount for your specific situation should be discussed with your doctor, particularly if you are taking other medications or managing a diagnosed condition.
CoQ10 comes in two primary forms: ubiquinone, the oxidised form, and ubiquinol, the reduced form. Ubiquinol is more readily absorbed, particularly for women over 35 or those with metabolic dysfunction. Both forms have appeared in fertility research. Because CoQ10 is fat-soluble, it should be taken with a meal that contains some fat for optimal absorption since taking it on an empty stomach reduces how much the body can actually use.
CoQ10 is generally considered safe at the doses used in research. Side effects are uncommon and tend to be mild; occasional nausea, headache, or difficulty sleeping if taken late in the evening. Taking it with food usually reduces any digestive discomfort.
The question of safety during pregnancy itself is important to address clearly. Most fertility protocols involve taking CoQ10 during the preconception period. Evidence on CoQ10 use after pregnancy is confirmed is limited, and the standard approach is to stop supplementation or consult your doctor once pregnancy is confirmed rather than continuing without guidance.
If you are taking prescription medications — including statins, blood thinners, or diabetes medications — discuss CoQ10 with your doctor before starting. There are known interactions that are worth reviewing for your specific situation.
CoQ10 is not a guarantee, and presenting it as one would undermine the very real and credible evidence that supports it. What the research does establish, particularly for women with PCOS, poor ovarian reserve, or those preparing for IVF, is a biologically coherent reason why CoQ10 matters and clinical evidence that its use is associated with better outcomes in these groups. The gaps in the evidence are real too: live birth data remains limited, and the benefits for younger women with no identified fertility challenges are less well-defined.
The most useful thing to take from this article is not a supplement decision. It is a clear enough understanding of the science to ask your doctor the right questions, about whether CoQ10 is relevant to your specific situation, at what dose, starting when, and alongside what else. That conversation, informed rather than rushed, is where the real value lies.
CoQ10 supports the mitochondrial function that egg maturation depends on, and research has shown improvements in the number and quality of eggs retrieved in IVF settings. Whether this consistently translates to better natural conception outcomes across all women is still being studied, but the biological mechanism is well-understood and the clinical evidence — particularly for PCOS and poor ovarian reserve — is encouraging.
Most fertility protocols suggest a minimum of 60 days before a conception attempt, because this corresponds to the time it takes for eggs to progress through the final stages of maturation. Some protocols extend this to 90 days as a more conservative window. Starting earlier is generally considered better than starting close to the attempted conception.
Research focused specifically on PCOS shows that CoQ10 can improve ovulation rates — including in women who have not responded to standard treatment — and may also improve insulin resistance and oxidative stress markers, both of which are central features of the condition. The 2014 RCT results on clomiphene-resistant PCOS are particularly relevant here.
Both are forms of CoQ10. Ubiquinol is the reduced, active form and is more efficiently absorbed, particularly as you get older or if your metabolic function is compromised. Ubiquinone is the more common form in supplements and converts to ubiquinol in the body, though this conversion becomes less efficient with age. For women over 35 or with metabolic challenges, ubiquinol may offer a meaningful absorption advantage.
The research on CoQ10 supplementation during pregnancy is limited. The standard practice is to stop once pregnancy is confirmed and consult your doctor about whether continuing is appropriate in your specific case, rather than assuming continuation is safe without guidance.
CoQ10 is generally compatible with commonly used preconception supplements including folic acid, iron, and Vitamin D. If you are on prescription medications, speak with your doctor before adding CoQ10, particularly if those medications affect blood sugar, blood pressure, or clotting.
